These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37683139)

  • 21. Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells.
    Irish JM; Czerwinski DK; Nolan GP; Levy R
    Blood; 2006 Nov; 108(9):3135-42. PubMed ID: 16835385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human follicular lymphoma cells contain oligomannose glycans in the antigen-binding site of the B-cell receptor.
    Radcliffe CM; Arnold JN; Suter DM; Wormald MR; Harvey DJ; Royle L; Mimura Y; Kimura Y; Sim RB; Inogès S; Rodriguez-Calvillo M; Zabalegui N; de Cerio AL; Potter KN; Mockridge CI; Dwek RA; Bendandi M; Rudd PM; Stevenson FK
    J Biol Chem; 2007 Mar; 282(10):7405-15. PubMed ID: 17197448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Grade I, II and III Follicular Lymphomas Express Ig V
    Csernus B; Timár B; Fülöp Z; Matolcsy A
    Pathol Oncol Res; 2020 Oct; 26(4):2765-2772. PubMed ID: 32705429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clonal expansion in follicular lymphoma occurs subsequent to antigenic selection.
    Zelenetz AD; Chen TT; Levy R
    J Exp Med; 1992 Oct; 176(4):1137-48. PubMed ID: 1402658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonstereotyped lymphoma B cell receptors recognize vimentin as a shared autoantigen.
    Cha SC; Qin H; Kannan S; Rawal S; Watkins LS; Baio FE; Wu W; Ong J; Wei J; Kwak B; Kim S; Popescu MS; Paick DS; Kim K; Luong A; Davis RE; Schroeder HW; Kwak LW; Neelapu SS
    J Immunol; 2013 May; 190(9):4887-98. PubMed ID: 23536634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic and epigenomic co-evolution in follicular lymphomas.
    Loeffler M; Kreuz M; Haake A; Hasenclever D; Trautmann H; Arnold C; Winter K; Koch K; Klapper W; Scholtysik R; Rosolowski M; Hoffmann S; Ammerpohl O; Szczepanowski M; Herrmann D; Küppers R; Pott C; Siebert R;
    Leukemia; 2015 Feb; 29(2):456-63. PubMed ID: 25027518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High Throughput Sequencing Analysis of the Immunoglobulin Heavy Chain Gene from Flow-Sorted B Cell Sub-Populations Define the Dynamics of Follicular Lymphoma Clonal Evolution.
    Carlotti E; Wrench D; Rosignoli G; Marzec J; Sangaralingam A; Hazanov L; Michaeli M; Hallam S; Chaplin T; Iqbal S; Calaminici M; Young B; Mehr R; Campbell P; Fitzgibbon J; Gribben JG
    PLoS One; 2015; 10(9):e0134833. PubMed ID: 26325507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Comparison of Immunoglobulin Variable Region N-Linked Glycosylation in Healthy Donors, Autoimmune Disease and Lymphoma.
    Vletter EM; Koning MT; Scherer HU; Veelken H; Toes REM
    Front Immunol; 2020; 11():241. PubMed ID: 32133009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphomas.
    Malpeli G; Barbi S; Moore PS; Scardoni M; Chilosi M; Scarpa A; Menestrina F
    Haematologica; 2004 Sep; 89(9):1091-9. PubMed ID: 15377470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in understanding the biology of follicular lymphoma.
    Nishikori M
    Int J Hematol; 2024 Mar; ():. PubMed ID: 38536645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole-exome sequencing.
    Zamò A; Pischimarov J; Schlesner M; Rosenstiel P; Bomben R; Horn H; Grieb T; Nedeva T; López C; Haake A; Richter J; Trümper L; Lawerenz C; Klapper W; Möller P; Hummel M; Lenze D; Szczepanowski M; Flossbach L; Schreder M; Gattei V; Ott G; Siebert R; Rosenwald A; Leich E
    Leukemia; 2018 Mar; 32(3):685-693. PubMed ID: 28824170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling.
    Myklebust JH; Brody J; Kohrt HE; Kolstad A; Czerwinski DK; Wälchli S; Green MR; Trøen G; Liestøl K; Beiske K; Houot R; Delabie J; Alizadeh AA; Irish JM; Levy R
    Blood; 2017 Feb; 129(6):759-770. PubMed ID: 28011673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell cross talk within the lymphoma tumor microenvironment: follicular lymphoma as a paradigm.
    Laurent C; Dietrich S; Tarte K
    Blood; 2024 Mar; 143(12):1080-1090. PubMed ID: 38096368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B-Lymphoblastic Lymphomas Evolving from Follicular Lymphomas Co-Express Surrogate Light Chains and Mutated Gamma Heavy Chains.
    Slot LM; Hoogeboom R; Smit LA; Wormhoudt TA; Biemond BJ; Oud ME; Schilder-Tol EJ; Mulder AB; Jongejan A; van Kampen AH; Kluin PM; Guikema JE; Bende RJ; van Noesel CJ
    Am J Pathol; 2016 Dec; 186(12):3273-3284. PubMed ID: 27750045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Next generation sequencing of the clonal IGH rearrangement detects ongoing mutations and interfollicular trafficking in in situ follicular neoplasia.
    Kosmidis P; Bonzheim I; Dufke C; Colak S; Hentrich T; Schroeder C; Bauer P; Adam P; Fend F
    PLoS One; 2017; 12(6):e0178503. PubMed ID: 28640838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insertion of atypical glycans into the tumor antigen-binding site identifies DLBCLs with distinct origin and behavior.
    Chiodin G; Allen JD; Bryant DJ; Rock P; Martino EA; Valle-Argos B; Duriez PJ; Watanabe Y; Henderson I; Blachly JS; McCann KJ; Strefford JC; Packham G; Geijtenbeek TBH; Figdor CG; Wright GW; Staudt LM; Burack R; Bowden TA; Crispin M; Stevenson FK; Forconi F
    Blood; 2021 Oct; 138(17):1570-1582. PubMed ID: 34424958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma.
    Burkhard R; Bhagat G; Cogliatti SB; Rossi D; Gaidano G; Pasqualucci L; Novak U
    Hematol Oncol; 2015 Mar; 33(1):23-30. PubMed ID: 24496723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Universal N-glycosylation sites introduced into the B-cell receptor of follicular lymphoma by somatic mutation: a second tumorigenic event?
    McCann KJ; Johnson PW; Stevenson FK; Ottensmeier CH
    Leukemia; 2006 Mar; 20(3):530-4. PubMed ID: 16437152
    [No Abstract]   [Full Text] [Related]  

  • 39. Mutational patterns along different evolution paths of follicular lymphoma.
    Michaeli M; Carlotti E; Hazanov H; Gribben JG; Mehr R
    Front Oncol; 2022; 12():1029995. PubMed ID: 36439408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Somatic hypermutation targeting to intrinsic hotspots of immunoglobulin genes in follicular lymphoma and multiple myeloma.
    Belessi C; Stamatopoulos K; Stavroyianni N; Zoi K; Papadaki T; Kosmas C
    Leukemia; 2001 Nov; 15(11):1772-8. PubMed ID: 11681420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.